Showing 1 - 20 results of 22 for search 'PHARMACOECONOMICS', query time: 0.53s Refine Results
  1. 1
    PHARMACOECONOMIC EFFECTIVENESS OF NAFTIDROFURYL IN PATIENTS WITH ISCHEMIC STROKE
    by A. N. Bogolepova, D. Yu. Belousov, A. E. Cheberda
    Published 2017-07-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  2. 2
    Comparative pharmacoeconomical analysis of modern antidepressants in monotherapy
    by A. E. Cheberda, D. Yu. Belousov, S. K. Zyryanov
    Published 2018-05-01
    “... disorders with several other important antidepressants using pharmacoeconomic methods within context...”
    Get full text
    Article
  3. 3
    Pharmacoeconomic analysis of naftidrofuryl for treatment of ischemic stroke
    by A. E. Cheberda, D. Yu. Belousov, A. N. Bogolepova
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  4. 4
    Pharmacoeconomic analysis of Cellex® in the treatment of ischemic stroke
    by A. E. Cheberda, D. Yu. Belousov
    Published 2018-06-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  5. 5
    PHARMACOECONOMIC ASSESSMENT OF INTERMITTENT AND CONTINUOUS RENAL REPLACEMENT THERAPY
    Get full text
    Article
  6. 6
    Comparative pharmacoeconomic analysis of Paclical® and Taxol® in Russian Federation
    by A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  7. 7
    Pharmacoeconomic analysis of subdermal tocilizumab in patients with rheumatoid arthritis
    by S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  8. 8
    Pharmacoeconomic analysis of Cocarnit® complex as treatment for diabetic polyneuropathy
    by D. Yu. Belousov, A. E. Cheberda
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  9. 9
    Pharmacoeconomic analysis of Xeomine® for treatment patients with focal dystonia
    by S. K. Zyryanov, D. Yu. Belousov, A. E. Cheberda
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  10. 10
    Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
    by A. E. Cheberda, D. Yu. Belousov, M. M. Shishkin
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  11. 11
    Pharmacoeconomic analysis of anti-VEGF therapy for age-related macular degeneration
    by A. E. Cheberda, D. Yu. Belousov, M. M. Shishkin
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  12. 12
    Pharmacoeconomic analysis of flexible-dose administration regimen of Xeomine® in patients with focal dystonia
    by A. E. Cheberda, D. Yu. Belousov, S. K. Zyryanov
    Published 2018-06-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  13. 13
    Pharmacoeconomic analysis of modern oral hypoglycemic agents with inadequate glycemic control on metformin
    “...The aim. Based on a pharmacoeconomic analysis (PHe) of the use of sodium-glucose cotransporter-2...”
    Get full text
    Article
  14. 14
    PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS
    by S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  15. 15
    Pharmacoeconomic analysis of naft idrofuryl in patients with chronic obliterating diseases of lower limb arteries
    by A. E. Cheberda, D. Yu. Belousov, M. R. Kuznetsov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  16. 16
    Comparative pharmacoeconomic analysis of oxycodone/naloxone combination analgesic and fentanyl transdermal delivery system
    by A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  17. 17
    Pharmacoeconomic analysis of Actemra<sup>®</sup> in first-line treatment of rheumatoid arthritis in the modes of combination and monotherapy
    by S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  18. 18
    Clinical and economic analysis of macrocyclic gadolinium-based compounds for use in magnetic resonance imaging diagnostics
    by A. E. Cheberda, D. U. Belousov
    Published 2020-01-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  19. 19
    CLINICAL AND ECONOMIC EVALUATION OF INHALATION ANESTHETICS USE
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  20. 20
    Clinico-economic analysis of PD-1 inhibitors and combinations of BRAF and MEK inhibitors for the treatment of metastatic melanoma with a BRAF V600 gene mutation
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search